Gencurix Publishes a Clinical Validation Study on GenesWell BCT, a New Breast Cancer Prognostic Test
SEOUL, South Korea--(BUSINESS WIRE)--On 28 March, Gencurix (KONEX:229000) announced that the results of clinical trials for the prediction of breast cancer prognosis were published in Scientific ...
SEOUL, South Korea, June 4, 2023 /PRNewswire/ -- Gencurix (KOSDAQ #229000), a leading provider of cancer molecular diagnostics, announced the release of clinical research results directly comparing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results